Medicine prices: is France still an attractive market?

In the European Union, decisions on pricing and reimbursement of medicinal products are made at a national level following negotiations between governments and Marketing Authorisation Holders (MAH). In France, after obtaining

Happy New Year 2023!

AxeRegel's team wishes you a wonderful year 2023!We wish you happiness, health and serenity. And more, we wish you a 2023 filled with opportunities, possibilities and, above all, personal well-being and professional dynamism.Make

Biosimilar medicines are interchangeable

The European Medicines Agency (EMA) and the Heads of Medicines Agencies (HMA) decided to harmonise EU position on interchangeability of biological medicines by issuing a joint statement confirming that biosimilar medicines approve

Qualified Person deputy in France

The status of Responsible Pharmacist in a pharmaceutical company is specific to France and is regulated by the Public Health Code (CSP).In France, any company with at least one pharmaceutical establishment must be owned by a pharm